Stage IIIA Colorectal Cancer AJCC v8 Recruiting Phase 2 Trials for Cetuximab (DB00002)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0109857 (Stage IIIA Colorectal Cancer AJCC v8) | Recruiting | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT04117945 | Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal Cancer | Treatment |